# A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers

> **NCT00463918** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 73 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** varenicline

## Key facts

- **NCT ID:** NCT00463918
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2008-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463918, "A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00463918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*